LIGAND PHARMACEUTICALS INCORPORATED Notes Payable, Current
LIGAND PHARMACEUTICALS INCORPORATED (LGND) had Notes Payable, Current of $224.53 million as of 2017-12-31, per its 10-K filed 2018-03-01.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt, Current Maturities
us-gaap:NotesPayableCurrent · last filed 2018-03-01
- 2017-12-31: Notes Payable, Current $224.53M.
- 2016-12-31: Notes Payable, Current $212.91M.
- 2015-12-31: Notes Payable, Current $201.99M.
- 2015-03-31: Notes Payable, Current $348.00K.
| Period end | Notes Payable, Current | Notes Payable, Current as first filed |
|---|---|---|
| 2017-12-31 | $224.53M 10-K · filed 2018-03-01 | |
| 2016-12-31 | $212.91M 10-K · filed 2018-03-01 | |
| 2015-12-31 | $201.99M 10-K · filed 2017-02-28 | |
| 2015-03-31 | $348.00K 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $334.00K 10-K · filed 2016-11-14 | $9.11M 10-K · filed 2014-12-01 |
| 2014-09-30 | $337.00K 10-Q · filed 2014-10-31 | |
| 2014-06-30 | $2.70M 10-Q · filed 2014-08-05 | |
| 2014-03-31 | $5.77M 10-Q · filed 2014-05-07 | |
| 2013-12-31 | $9.11M 10-K · filed 2015-02-23 | |
| 2013-09-30 | $12.38M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $13.60M 10-Q · filed 2013-08-01 | |
| 2013-03-31 | $13.21M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $14.84M 10-K/A · filed 2014-12-12 | |
| 2012-09-30 | $10.27M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $5.81M 10-Q/A · filed 2012-11-14 | |
| 2012-03-31 | $1.44M 10-Q/A · filed 2012-11-14 |